The results of clinical use of mTOR inhibitors, in particular, everolimus, in immunosuppressive therapy regimens. Reasons why immunosuppressive therapy regimens including mTOR inhibitors are preferred in patients with high and moderate risk of graft loss.
При низкой оригинальности работы "Change of the pattern of management of the renal transplant patients with terminal stage of chronic renal failure", Вы можете повысить уникальность этой работы до 80-100%
